Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Curr Opin Investig Drugs. 2009 Feb;10(2):121-8.

Ribosomal frameshifting: an emerging drug target for HIV.

Author information

  • 1University of Rochester, Department of Dermatology, Rochester, New York, NY 14642, USA.

Abstract

Combating HIV currently remains one of the key public health challenges. While immense effort has been invested in the development of HIV-targeted therapeutic agents, interfering with protein synthesis is a relatively unexplored area. HIV has an absolute requirement for a -1 ribosomal frameshift event during translation that constitutes a potentially attractive target for interfering with the viral life cycle. Research suggests that while a considerable amount of investigation is still required, targeting frameshifting in HIV with small molecules, peptides and oligonucleotides is feasible.

PMID:
19197789
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk